Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Understanding the Cost and Funding of Gene Ther...
By
HEOR Staff Writer
July 31, 2024
Introduction Gene therapy is rapidly transforming the treatment landscape for rare diseases. With innovations like CAR T-cell therapy and CRISPR...
The Power of Paediatric Biobanks: Advancing Child Health Research
Abu Dhabi Strategic Healthcare Partnerships: Global Collaborations
Genome-Wide Sequencing in Diagnosing Rare Diseases: Clinical and Economic Imp...
Rare Diseases: Modern Strategies for Enhanced Primary Care
Challenges and Opportunities in Educating the Public About Childhood Arthriti...
Access to Essential Medicines for Rheumatic Diseases in Children
Paediatric Rheumatology Care in Africa: Hope and Resilience
Juvenile Arthritis: Meeting the Benchmark with Health Technology
Enhancing Early Diagnosis and Care for Juvenile Idiopathic Arthritis
The Role of Pull Incentives in Addressing Antimicrobial Resistance
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Impact of Time Horizons on QALY Calculations in Healthcare
« Previous
1
2
3
4
5
Next »